Respiratory symptoms/diseases, impaired lung function, and drug use in two Italian general population samples

Respiratory Medicine

Volumn 102, Issue 1, 2008, Pages 82-91

  Simoni, Marzia ^a   Carrozzi, Laura ^b   Baldacci, Sandra ^a   Borbotti, Marco ^a   Pistelli, Francesco ^b   Di Pede, Francesco ^b   Maio, Sara ^a   Angino, Anna ^a   Viegi, Giovanni ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Airflow obstruction; Drug use; Epidemiological study; General population; Medicines; Respiratory disorders

Indexed keywords

ANTIALLERGIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CARDIOVASCULAR AGENT; CORTICOSTEROID; DIURETIC AGENT; METHYLXANTHINE;

ADOLESCENT; ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DRUG USE; EPIDEMIOLOGICAL DATA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; ITALY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; POPULATION RESEARCH; PREDICTOR VARIABLE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK FACTOR; RURAL AREA; SCHOOL CHILD; STATISTICAL ANALYSIS; URBAN AREA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ALLERGIC AGENTS; ASTHMA; ATTITUDE TO HEALTH; BRONCHODILATOR AGENTS; CARDIOVASCULAR AGENTS; CHILD; CHILD, PRESCHOOL; DIURETICS; HUMANS; ITALY; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; RESPIRATION DISORDERS; RURAL HEALTH; TREATMENT REFUSAL;

EID: 36348982188     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.08.002     Document Type: Article

References (49)

1. Barbour M.M., Hume A.L., Assaf A.R., and Carleton R.A. The drug data base of the Pawtucket Heart Health Program: development and description. Pharmacotherapy 13 (1993) 239-243
2. Lau H.S., de Boer A., Beuning K.S., and Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 50 (1997) 619-625
3. Thormodsen M., Fonnelop H., Rytter E., and Torisen H.M. To be used as directed by your physician. Reasons why patients do not use prescribed medicines. Tidsskr Nor Laegeforen 117 (1997) 3517-3520
4. Cerveri I., Zoia M.C., Bugiani M., Corsico A., Carosso A., Piccioni P., et al. Inadequate antiasthma drug use in the north of Italy. Eur Respir J 10 (1997) 2761-2765
5. Paterson N.A., Peat J.K., Mellis C.M., Xuan W., and Woolcock A.J. Accuracy of asthma treatment in schoolchildren in NSW, Australia. Eur Respir J 10 (1997) 658-664
6. Janson C., Chinn S., Jarvis D., and Burney P. Individual use of antiasthmatic drugs in the European Community Respiratory Health Survey. Eur Respir J 12 (1998) 557-563
7. Rabe K.F., Adachi M., Lai C.K., Soriano J.B., Vermeire P.A., Weiss K.B., et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 114 (2004) 40-47
8. Tronetti P.S., Grecely E.J., and Boscia J.A. Lack of association between medication use and the presence or absence of bacteriuria in elderly women. J Am Geriatr Soc 38 (1990) 1199-1202
9. Rothenbacher D., Bode G., Adler G., and Brenner H. Use of commonly prescribed antibiotics is not associated with prevalence of Helicobacter pylori infection in adults. Scand J Gastroenterol 32 (1997) 1096-1099
10. Van den Brandt P.A., Petri H., Goldbohm R.A., and Van de Crommert S. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl 13 (1991) 91-96
11. Wieringa M.H., Weyler J.J., Nelen V.J., Van Hoof K.J., Van Bastelaer F.J., Van Sprundel M.P., et al. Prevalence of respiratory symptoms: marked differences within a small geographical area. Int J Epidemiol 27 (1998) 630-635
12. Soriano J.B., Visick G.T., Muellerova H., Payvandi N., and Hansell A.L. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 128 (2005) 2099-2107
13. Kiljander T.O., and Laitinen J.O. The prevalence of gastroesophageal reflux disease in adult asthmatics. Chest 126 (2004) 1490-1494
14. Iribarren C., Tolstykh I.V., and Eisner M.D. Are patients with asthma at increased risk of coronary heart disease?. Int J Epidemiol 33 (2004) 743-748
15. Carrozzi L., Giuliano G., Viegi G., et al. The Po River Delta epidemiological study of obstructive lung disease: sampling methods, environmental and population characteristics. Eur J Epidemiol 6 (1990) 191-200
16. Viegi G., Paoletti P., Prediletto R., Carrozzi L., Fazzi P., Di Pede F., et al. Prevalence of respiratory symptoms in an unpolluted area of northern Italy. Eur Respir J 1 (1988) 311-318
17. Baldacci S., Carrozzi L., Viegi G., and Giuntini C. Assessment of respiratory effect of air pollution: study design on general population samples. JEPTO 16 (1997) 77-83
18. Viegi G., Paoletti P., Carrozzi L., Vellutini M., Diviggiano E., Di Pede C., et al. Prevalence rates of respiratory symptoms in Italian general population samples exposed to different levels of air pollution. Environ Health Perspect 94 (1991) 95-99
19. Viegi G., Carrozzi L., Di Pede F., Baldacci S., Pedreschi P., Modena P., et al. Risk factors for chronic obstructive pulmonary disease in a North Italian rural area. Eur J Epidemiol 10 (1994) 725-731
20. Simoni M., Pedreschi M., Baldacci S., Pistelli F., Carrozzi L., Sapigni T., et al. The Po river Delta epidemiological study: use of medicines in a general population sample of North Italy. Pharmacoepidemiol Drug Saf 9 (2000) 319-326
21. Informatore Farmaceutico. OEMF SpA, Via Edolo, 42, 20125 Milano; 1989.
22. American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev Respir Dis 136 (1987) 1285-1298
23. Paoletti P., Pistelli G., Fazzi P., Viegi G., Di Pede F., Giuliano G., et al. Reference values for vital capacity and flow-volume curves from a general population study. Bull Eur Physiopathol Respir 22 (1986) 451-459
24. Viegi G., Pedreschi M., Pistelli F., Di Pede F., Baldacci S., Carrozzi L., et al. Prevalence of airways obstruction in a general population. Chest 117 (2000) 339S-345S
25. Pauwels R.A., Buist S., Calverley P., Jenkins C., and Hurd S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 1256-1276
26. SPSS, Rel. 9.0. Spss Inc., Chicago, 1999. SPSS/PC+update for 10.1 SPSS Inc., Chicago, 2000.
27. Montnemery P., Adelroth E., Heuman K., Johannisson A., Johansson S.A., Lindholm L.H., et al. Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden. Respir Med 92 (1998) 1337-1345
28. Yemaneberhan H., Bekele Z., Venn A., Lewis S., Parry E., and Britton J. Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet 350 (1997) 85-90
29. Lewis S., Hales S., Slater T., Pearce N., Crane J., and Beasley R. Geographical variation in the prevalence of asthma symptoms in New Zealand. N Z Med J 110 (1997) 286-289
30. Brunekreef B., and Holgate S.T. Air pollution and health. Lancet 360 (2002) 1233-1242
31. Grella E., Paciocco G., Caterino U., and Mazzarella G. Respiratory function and atmospheric pollution. Monaldi Arch Chest Dis 57 (2002) 196-199
32. Masjedi M.R., Jamaati H.R., Dokouhaki P., Ahmadzadeh Z., Taheri S.A., Bigdeli M., et al. The effects of air pollution on acute respiratory conditions. Respirology 8 (2003) 213-230
33. Paggiaro P.L., Viegi G., Filieri M., Di Pede F., Serretti N., Giuntini C., et al. Confronto tra uno spirometro a pistone e uno pneumotacografo con sistema computerizzato. Medicina del Lavoro 6 (1981) 494-504
34. Pistelli G., Carmignani G., Paoletti P., Di Pede F., Viegi G., Carrozzi L., et al. Comparison of algorithms for determining the end-point of the forced vital capacity maneuver. Chest 91 (1987) 100-105
35. Scalera A.R., Di Pede F., Pistelli F., Fornai E., Carrozzi L., Pistelli G., et al. Variabilità dei parametri di funzione respiratoria misurati con tre diversi strumenti. Med Toracica 19 (1997) 13-20
36. Baum C., Kennedy D.L., Knapp D.E., Juergens J.P., and Faich G.A. Prescription drug e use in 1984 and changes over time. Med Care 26 (1988) 105-114
37. Osterlind P.O., and Bucht G. Drug consumption during the last decade among persons born in 1902 in Umea, Sweden. A longitudinal population study. Drugs Aging 1 (1991) 477-486
38. Nolan L., and O'Malley K. Age-related prescribing patterns in general practice. Compr Gerontol 1 (1987) 97-101
39. Vega Quiroga S., Lopez Gay L., Bermejo Pareja F., de la Rosa Gil L., de Bustos Tabernero M., Sampedro Lopez M.D., et al. Drug consumption by people over 60 years of age in a rural area. Aten Primaria 17 (1996) 496-500
40. Progetto ARNO. Osservatorio sulla prescrizione farmaceutica. Rapporto 1995-1996. Cineca; 1997.
41. Hajat S., Anderson H.R., Atkinson R.W., and Haines A. Effects of air pollution on general practitioner consultations for upper respiratory diseases in London. Occup Environ Med 59 (2002) 294-299
42. Cutts C., and Tett S.E. Doctors perceptions of the influence on their prescribing: a comparison of general practitioners based in rural and urban Australia. Eur Clin Pharmacol 58 (2003) 761-766
43. Pistelli R., Lange P., and Miller D.L. Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity. Eur Respir J 40 (2003) s10-s14
44. van den Boom G., Rutten-van Mölken M.P.M.H., Tirimanna P.R.S., van Schayck C.P., Folgering H., and van Weel C. Association between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programme. Eur Respir J 11 (1998) 67-72
45. Cerveri I., Locatelli F., Zoia M.C., Corsico A., Accordini S., and de Marco R. International variation in asthma treatment compliance. Eur Respir J 14 (1999) 288-294
46. Viegi G., Matteelli G., Angini A., Scognamiglio A., Baldacci S., Soriano J.B., et al. The proportional Venn diagram of obstructive lung disease in the Italian general population. Chest 126 (2004) 1093-1101
47. National Asthma Education Program-Expert Panel report guidelines for the diagnosis and management of asthma. US Department of Health and Human Service Public Health Service National Institute of Health Publication No. 91-3042; August 1991.
48. National Asthma Education and Prevention Program Expert Panel. Report: guidelines for the diagnosis and management of asthma. Update on selected topics. J Allergy Clin Immunol 110 (2002) s141-s219
49. Fabbri L.M., and Hurd S.S. for the GOLD Scientific Committee. Eur Respir J 22 (2003) 1-2